US BANCORP \DE\ - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,171 filers reported holding NOVARTIS A G in Q4 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$23,946,369
+14.0%
235,091
+12.9%
0.04%
+14.7%
Q2 2023$21,003,911
+11.6%
208,145
+1.7%
0.03%
+6.2%
Q1 2023$18,824,856
-10.5%
204,618
-11.8%
0.03%
-13.5%
Q4 2022$21,036,062
+44.6%
231,879
+21.2%
0.04%
+23.3%
Q3 2022$14,545,000
-33.4%
191,342
-25.9%
0.03%
-28.6%
Q2 2022$21,834,000
+5.0%
258,296
+9.0%
0.04%
+20.0%
Q1 2022$20,785,000
-3.9%
236,862
-4.2%
0.04%
+2.9%
Q4 2021$21,639,000
-13.1%
247,372
-18.7%
0.03%
-27.7%
Q3 2021$24,887,000
-15.7%
304,305
-6.0%
0.05%
-14.5%
Q2 2021$29,528,000
+13.6%
323,621
+6.4%
0.06%
+3.8%
Q1 2021$26,001,000
-6.8%
304,177
+2.9%
0.05%
-11.7%
Q4 2020$27,911,000
+11.4%
295,571
+2.6%
0.06%
-1.6%
Q3 2020$25,047,000
-9.1%
288,035
-8.7%
0.06%
-15.3%
Q2 2020$27,560,000
+4.1%
315,538
-1.7%
0.07%
-13.3%
Q1 2020$26,469,000
+15.1%
321,043
+32.2%
0.08%
+40.7%
Q4 2019$22,994,000
+11.2%
242,833
+2.1%
0.06%
+5.4%
Q3 2019$20,674,000
+15.5%
237,923
+21.4%
0.06%
+12.0%
Q2 2019$17,901,000
-17.9%
196,047
-13.6%
0.05%
-20.6%
Q1 2019$21,814,000
-13.5%
226,897
-22.8%
0.06%
-22.2%
Q4 2018$25,222,000
+17.8%
293,928
+18.3%
0.08%
+30.6%
Q3 2018$21,410,000
+29.0%
248,494
+13.1%
0.06%
+21.6%
Q2 2018$16,591,000
-1.2%
219,644
+5.8%
0.05%
-1.9%
Q1 2018$16,787,000
-16.7%
207,635
-13.5%
0.05%
-16.1%
Q4 2017$20,152,000
+7.1%
240,011
+9.5%
0.06%
+3.3%
Q3 2017$18,822,000
-0.0%
219,233
-2.8%
0.06%
-4.8%
Q2 2017$18,828,000
-19.1%
225,559
-28.0%
0.06%
-21.2%
Q1 2017$23,277,000
-0.7%
313,403
-2.6%
0.08%
-4.8%
Q4 2016$23,434,000
+0.3%
321,724
+8.7%
0.08%
-3.4%
Q3 2016$23,374,000
+11.8%
296,017
+16.8%
0.09%
+8.8%
Q2 2016$20,916,000
+2.6%
253,486
-10.0%
0.08%0.0%
Q1 2016$20,395,000
-29.5%
281,559
-16.3%
0.08%
-31.0%
Q4 2015$28,932,000
-10.6%
336,273
-4.5%
0.12%
-14.7%
Q3 2015$32,357,000
-8.8%
352,021
-2.4%
0.14%
-0.7%
Q2 2015$35,475,000
+0.7%
360,735
+1.0%
0.14%
+1.5%
Q1 2015$35,226,000
+4.4%
357,230
-1.9%
0.14%
+3.8%
Q4 2014$33,728,000
+6.2%
364,000
+7.9%
0.13%
+0.8%
Q3 2014$31,768,000
+12.7%
337,491
+8.4%
0.13%
+15.2%
Q2 2014$28,182,000
+14.4%
311,296
+7.5%
0.11%
+10.9%
Q1 2014$24,630,000
+9.1%
289,699
+3.1%
0.10%
+11.0%
Q4 2013$22,581,000
+10.7%
280,932
+5.6%
0.09%
+1.1%
Q3 2013$20,401,000
+4.5%
265,949
-3.6%
0.09%
+1.1%
Q2 2013$19,515,000275,9790.09%
Other shareholders
NOVARTIS A G shareholders Q4 2022
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders